Simplex Trading’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,862
Closed -$214K 11881
2021
Q4
$214K Buy
7,862
+564
+8% +$15.3K ﹤0.01% 5095
2021
Q3
$132K Buy
7,298
+335
+5% +$8.28K ﹤0.01% 6236
2021
Q2
$118K Sell
6,963
-17,557
-72% -$329K ﹤0.01% 6497
2021
Q1
$511K Buy
24,520
+16,377
+201% +$378K ﹤0.01% 3340
2020
Q4
$186K Buy
8,143
+4,028
+98% +$76.7K ﹤0.01% 4715
2020
Q3
$67K Buy
4,115
+3,339
+430% +$60.5K ﹤0.01% 5339
2020
Q2
$10K Sell
776
-81
-9% -$942 ﹤0.01% 6681
2020
Q1
$10K Buy
+857
New +$19K ﹤0.01% 6493
2019
Q3
Sell
-464
Closed -$8.45K 8139
2019
Q2
$10K Buy
+464
New +$12.5K ﹤0.01% 6132
2018
Q2
Sell
-547
Closed -$21.5K 8092
2018
Q1
$21K Sell
547
-6,948
-93% -$254K ﹤0.01% 3326
2017
Q4
$242K Buy
+7,495
New +$225K 0.01% 1147
2017
Q1
Sell
-2,795
Closed -$33K 7025
2016
Q4
$33K Buy
+2,795
New +$36.2K ﹤0.01% 2579

Other funds holding XENT

Simplex Trading's XENT Position: Q1 2022 in Review

Simplex Trading sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 7,862 shares — an estimated $214K sold.

Simplex Trading first reported a position in XENT in Q4 2016 and held it in 12 quarters. The position peaked at $511K in Q1 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Simplex Trading reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 7,862 Intersect ENT, Inc shares in Q1 2022, an estimated $214K.
  • Simplex Trading first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 12 quarters.
  • Simplex Trading's Intersect ENT, Inc position peaked at $511K in Q1 2021.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.